FACTOR-VII ANTIGEN LEVELS IN A HEALTHY BLOOD-DONOR POPULATION

被引:0
|
作者
HOWARD, PR
BOVILL, EG
PIKE, J
CHURCH, WR
TRACY, RP
机构
[1] UNIV VERMONT,DEPT MED TECHNOL,BURLINGTON,VT
[2] UNIV VERMONT,DEPT PATHOL,BURLINGTON,VT 05405
[3] UNIV VERMONT,DEPT BIOCHEM,VERMONT THROMBOSIS CTR,BURLINGTON,VT 05405
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined factor VII antigen (FVIIag) levels in 705 healthy blood donors ranging in age from 17 to 79 years using a two-site solid-phase enzyme immunoassay developed in our laboratory. The mean (+/- SD) FVIIag level for the total population was 102 +/- 31%. FVIIag levels for men (n = 375) and women (n = 330) were 101 +/- 28% and 103 +/- 33%, respectively. A significant increase in FVIIag was observed with age in both men (r = 0.25, p <0.0001) and women (r = 0.35, p <0.0001). FVIIag levels were significantly higher in women >60 years when compared to men (median women: 125%; median men: 111%; p <0.05). On a subset of the study group (n = 45), FVIIag levels were correlated to total cholesterol (r = 0.27, p = 0.08) and triglyceride (r = 0.41,p <0.01). Assuming the commonly used reference interval of 60-140% for FVII, the frequencies of FVIIag values for <60% and >140% using our assay were 2.1% and 9.2%, respectively. Gender and age-related differences in FVIIag levels must be considered in a reference interval. We further suggest that assay-specific reference ranges be established, which may include values outside the commonly used values of 60-140%.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [21] CAUSES OF DISQUALIFICATION IN A VOLUNTEER BLOOD-DONOR POPULATION
    FARRALES, FB
    STEVENSON, AR
    BAYER, WL
    TRANSFUSION, 1977, 17 (06) : 598 - 601
  • [22] FACTOR VIP COAGULANT ACTIVITY AND ANTIGEN LEVELS IN HEALTHY-MEN ARE DETERMINED BY INTERACTION BETWEEN FACTOR-VII GENOTYPE AND PLASMA TRIGLYCERIDE CONCENTRATION
    HUMPHRIES, SE
    LANE, A
    GREEN, FR
    COOPER, J
    MILLER, GJ
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (02): : 193 - 198
  • [23] ELEVATED LEVELS OF FACTOR-VII ACTIVITY IN THE POSTPRANDIAL STATE - EFFECT OF THE FACTOR-VII ARG-GLN POLYMORPHISM
    SILVEIRA, A
    GREEN, F
    KARPE, F
    BLOMBACK, M
    HUMPHRIES, S
    HAMSTEN, A
    THROMBOSIS AND HAEMOSTASIS, 1994, 72 (05) : 734 - 739
  • [24] CORRELATION OF FACTOR-VII ACTIVITY AND ANTIGEN WITH CHOLESTEROL AND TRIGLYCERIDES IN HEALTHY-YOUNG MEN AND WOMEN
    HULTIN, MB
    HOFFMAN, CJ
    MILLER, RH
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 920 - 920
  • [25] QUANTITATION OF ACTIVATED FACTOR-VII LEVELS IN PLASMA USING A TISSUE FACTOR MUTANT SELECTIVELY DEFICIENT IN PROMOTING FACTOR-VII ACTIVATION
    MORRISSEY, JH
    MACIK, BG
    NEUENSCHWANDER, PF
    COMP, PC
    BLOOD, 1993, 81 (03) : 734 - 744
  • [26] INCIDENCE AND SIGNIFICANCE OF HEPATITIS-B CORE ANTIBODY IN A HEALTHY BLOOD-DONOR POPULATION
    KITCHEN, AD
    HARRISON, TJ
    MEACOCK, TJ
    ZUCKERMAN, AJ
    HARRISON, JF
    JOURNAL OF MEDICAL VIROLOGY, 1988, 25 (01) : 69 - 75
  • [27] BLOOD-GLUCOSE MAY CONDITION FACTOR-VII LEVELS IN DIABETIC AND NORMAL SUBJECTS
    CERIELLO, A
    GIUGLIANO, D
    QUATRARO, A
    DELLORUSSO, P
    TORELLA, R
    DIABETOLOGIA, 1988, 31 (12) : 889 - 891
  • [28] INTERACTION OF HUMAN-BLOOD COAGULATION FACTOR-VII AND TISSUE FACTOR - EFFECT OF ANTI FACTOR-VII, ANTI TISSUE FACTOR AND DIISOPROPYLFLUOROPHOSPHATE
    OSTERUD, B
    BJORKLID, E
    BROWN, SF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 88 (01) : 59 - 67
  • [29] THE IMPORTANCE OF RESIDUES 195-206 OF HUMAN BLOOD-CLOTTING FACTOR-VII IN THE INTERACTION OF FACTOR-VII WITH TISSUE FACTOR
    WILDGOOSE, P
    KAZIM, AL
    KISIEL, W
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 7290 - 7294
  • [30] GENETIC DETERMINATION OF COAGULATION FACTOR-VII LEVELS AMONG HEALTHY MIDDLE-AGED WOMEN
    MEILAHN, E
    HUMPHRIES, S
    GREEN, F
    TEMPLE, A
    KISS, J
    KULLER, L
    FERRELL, R
    CIRCULATION, 1992, 85 (02) : 882 - 882